Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1391 ARTÍCULOS , VIENDO DEL 586 AL 600
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.
Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.
Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease
Kalra J, Khan A.
Eur J Pharmacol. 2015 Oct 5;764:571-581. doi: 10.1016/j.ejphar.2015.07.043. Epub 2015 Jul 21.
Drawing in Alzheimer-type dementia
Fichera M, Bernasconi MP, Martinelli V, Comi G, Volonté MA.
Neurology. 2015 Jul 28;85(4):386-7. doi: 10.1212/WNL.0000000000001789.
Manzo C.
Recenti Prog Med. 2015 Jul;106(7):342-3. doi: 10.1701/1940.21094.
Du L, Feng HW, Li YY.
Yao Xue Xue Bao. 2015 May;50(5):528-34.
Cognitively Impaired Sexually Abused Women: The Most Vulnerable of All?
Tullmann D.
Issues Ment Health Nurs. 2015 Jun;36(6):474-7. doi: 10.3109/01612840.2014.994690.
Panke-Kochinke B, Krause G, Klimann O.
Pflege. 2015 Aug;28(4):219-32. doi: 10.1024/1012-5302/a000435.
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease
Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, Sperling R, Salloway S, Schofield PR, Masters CL, Martins RN, Rossor MN, Jucker M, Danek A, Förster S, Lane CA, Morris JC, Benzinger TL, Bateman RJ; Dominantly Inherited Alzheimer Network.
Neurology. 2015 Sep 1;85(9):790-8. doi: 10.1212/WNL.0000000000001903. Epub 2015 Aug 5.
Is dominantly inherited Alzheimer disease a clone of sporadic Alzheimer disease?
Knopman DS.
Neurology. 2015 Sep 1;85(9):750-1. doi: 10.1212/WNL.0000000000001897. Epub 2015 Aug 5.
Becker RE, Seeman MV, Greig NH, Lahiri DK.
Lancet Psychiatry. 2015 Aug;2(8):756-764. doi: 10.1016/S2215-0366(15)00214-X.
Current thinking on the mechanistic basis of Alzheimer's and implications for drug development
Ising C, Stanley M, Holtzman DM.
Clin Pharmacol Ther. 2015 Nov;98(5):469-71. doi: 10.1002/cpt.200. Epub 2015 Sep 10.
Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis
Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, Barboni P, Pierelli F, Sadun AA, Parisi V.
PLoS One. 2015 Aug 7;10(8):e0134750. doi: 10.1371/journal.pone.0134750. eCollection 2015.
Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer's disease
Carmona P, Molina M, López-Tobar E, Toledano A.
Anal Bioanal Chem. 2015 Oct;407(25):7747-56. doi: 10.1007/s00216-015-8940-7. Epub 2015 Aug 9.
Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir
Trembath L, Newell M, Devous MD Sr.
J Nucl Med Technol. 2015 Sep;43(3):175-84. doi: 10.2967/jnmt.115.156679. Epub 2015 Aug 13.
Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease
Leurent C, Ehlers MD.
Clin Pharmacol Ther. 2015 Nov;98(5):475-6. doi: 10.1002/cpt.212. Epub 2015 Sep 8.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.